17.BETA.-HYDROXY-2-OXAESTRA-4,9-DIENE-3-ONE
UNII 89VB2PL504

Substance Identification & Data

This profile provides standardized clinical and technical data for 17.beta.-hydroxy-2-oxaestra-4,9-diene-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 89VB2PL504.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 20111-37-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

89VB2PL504

CAS Registry Number

20111-37-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

17.BETA.-HYDROXY-2-OXAESTRA-4,9-DIENE-3-ONE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C17H22O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LBTIEDJPUIYGLT-DYWXZXKOSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

131801043

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C12=C3[C@@]([C@@]4(CC[C@@H]([C@]4(CC3)C)O)[H])([H])CCC1=CC(OC2)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 17.beta.-hydroxy-2-oxaestra-4,9-diene-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.